128 related articles for article (PubMed ID: 9522214)
1. Apoptosis in thyroid neoplasms: relationship with p53 and bcl-2 expression.
Moore D; Ohene-Fianko D; Garcia B; Chakrabarti S
Histopathology; 1998 Jan; 32(1):35-42. PubMed ID: 9522214
[TBL] [Abstract][Full Text] [Related]
2. Prevalences of Gs alpha, ras, p53 mutations and ret/PTC rearrangement in differentiated thyroid tumours in a Korean population.
Park KY; Koh JM; Kim YI; Park HJ; Gong G; Hong SJ; Ahn IM
Clin Endocrinol (Oxf); 1998 Sep; 49(3):317-23. PubMed ID: 9861322
[TBL] [Abstract][Full Text] [Related]
3. Bax expression in benign and malignant thyroid tumours: dysregulation of wild-type P53 is associated with a high Bax and P21 expression in thyroid carcinoma.
Hermann S; Sturm I; Mrozek A; Klosterhalfen B; Hauptmann S; Dörken B; Daniel PT
Int J Cancer; 2001 Jun; 92(6):805-11. PubMed ID: 11351299
[TBL] [Abstract][Full Text] [Related]
4. Expression of bcl-2, c-erbB-2, p53, and p21 (waf1-cip1) protein in thyroid carcinomas.
Soda G; Antonaci A; Bosco D; Nardoni S; Melis M
J Exp Clin Cancer Res; 1999 Sep; 18(3):363-7. PubMed ID: 10606183
[TBL] [Abstract][Full Text] [Related]
5. Expression of Pax-8, p53 and bcl-2 in human benign and malignant thyroid diseases.
Puglisi F; Cesselli D; Damante G; Pellizzari L; Beltrami CA; Di Loreto C
Anticancer Res; 2000; 20(1A):311-6. PubMed ID: 10769673
[TBL] [Abstract][Full Text] [Related]
6. Bcl-2 and p53 expression in insular and in well-differentiated thyroid carcinomas with an insular pattern.
Peştereli HE; Oğüş M; Oren N; Karpuzoğlu G; Kerpuzoğlu T
Endocr Pathol; 2001; 12(3):301-5. PubMed ID: 11740051
[TBL] [Abstract][Full Text] [Related]
7. Expression of the cell death-inducing gene bax in carcinomas developed from the follicular cells of the thyroid gland.
Branet F; Brousset P; Krajewski S; Schlaifer D; Selves J; Reed JC; Caron P
J Clin Endocrinol Metab; 1996 Jul; 81(7):2726-30. PubMed ID: 8675602
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland.
Pilotti S; Collini P; Rilke F; Cattoretti G; Del Bo R; Pierotti MA
J Pathol; 1994 Apr; 172(4):337-42. PubMed ID: 8207614
[TBL] [Abstract][Full Text] [Related]
9. [Bcl-2 proto-oncogene expression in neoplastic and non neoplastic thyroid tissue].
Branet F; Caron P; Camallières M; Selves J; Brousset P
Bull Cancer; 1996 Mar; 83(3):213-7. PubMed ID: 8695923
[TBL] [Abstract][Full Text] [Related]
10. Apoptosis and expression of Bax, Bcl-x, and Bcl-2 apoptotic regulatory proteins in colorectal carcinomas, and association with p53 genotype/phenotype.
De Angelis PM; Stokke T; Thorstensen L; Lothe RA; Clausen OP
Mol Pathol; 1998 Oct; 51(5):254-61. PubMed ID: 10193519
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis and proliferation in thyroid carcinoma: correlation with bcl-2 and p53 protein expression.
Basolo F; Pollina L; Fontanini G; Fiore L; Pacini F; Baldanzi A
Br J Cancer; 1997; 75(4):537-41. PubMed ID: 9052406
[TBL] [Abstract][Full Text] [Related]
12. p53 expression in anaplastic carcinomas arising from thyroid papillary carcinomas.
Matias-Guiu X; Cuatrecasas M; Musulen E; Prat J
J Clin Pathol; 1994 Apr; 47(4):337-9. PubMed ID: 8027371
[TBL] [Abstract][Full Text] [Related]
13. bcl-2, p53 and proliferating cell nuclear antigen expression is related to the degree of differentiation in thyroid carcinomas.
Pollina L; Pacini F; Fontanini G; Vignati S; Bevilacqua G; Basolo F
Br J Cancer; 1996 Jan; 73(2):139-43. PubMed ID: 8546897
[TBL] [Abstract][Full Text] [Related]
14. p53 mutations in childhood thyroid tumours from Belarus and in thyroid tumours without radiation history.
Smida J; Zitzelsberger H; Kellerer AM; Lehmann L; Minkus G; Negele T; Spelsberg F; Hieber L; Demidchik EP; Lengfelder E; Bauchinger M
Int J Cancer; 1997 Dec; 73(6):802-7. PubMed ID: 9399655
[TBL] [Abstract][Full Text] [Related]
15. Apoptosis is inversely related to bcl-2 but not to bax expression in salivary gland tumours.
Soini Y; Törmänen U; Pääkkö P
Histopathology; 1998 Jan; 32(1):28-34. PubMed ID: 9522213
[TBL] [Abstract][Full Text] [Related]
16. p53 protein, PCNA staining, and DNA content in follicular neoplasms of the thyroid gland.
Czyz W; Joensuu H; Pylkkänen L; Klemi PJ
J Pathol; 1994 Dec; 174(4):267-74. PubMed ID: 7884588
[TBL] [Abstract][Full Text] [Related]
17. Low expression of bcl-2 in Brca1-associated breast cancers.
Freneaux P; Stoppa-Lyonnet D; Mouret E; Kambouchner M; Nicolas A; Zafrani B; Vincent-Salomon A; Fourquet A; Magdelenat H; Sastre-Garau X
Br J Cancer; 2000 Nov; 83(10):1318-22. PubMed ID: 11044356
[TBL] [Abstract][Full Text] [Related]
18. Expression of Bcl-2 in lung neuroendocrine tumours: comparison with p53.
Wang DG; Johnston CF; Sloan JM; Buchanan KD
J Pathol; 1998 Mar; 184(3):247-51. PubMed ID: 9614375
[TBL] [Abstract][Full Text] [Related]
19. Retinoblastoma and p53 tumour suppressor gene protein expression in carcinomas of the thyroid gland.
Holm R; Nesland JM
J Pathol; 1994 Mar; 172(3):267-72. PubMed ID: 8195930
[TBL] [Abstract][Full Text] [Related]
20. p53, MDM2, bcl-2 staining in follicular neoplasms of the thyroid gland.
Czyz W; Kuzdak K; Pasieka Z; Timler D; Brzeziński J
Folia Histochem Cytobiol; 2001; 39 Suppl 2():167-8. PubMed ID: 11820589
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
